Jimmy Fund Press Releases
U.S. News & World Report has ranked Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #3 in the nation.
Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphomaMay 01, 2018
Dana-Farber is a certified treatment center for the just approved CAR T-cell therapy, tisagenlecleucel (Kymriah™) for certain lymphoma patients.
Researchers launched the Metastatic Prostate Cancer Project (MPC), a patient-partnered initiative that encourages men with metastatic prostate cancer across the U.S. and Canada to collaborate.